医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
2-三氟甲基吡啶-5-硼酸频哪醇酯 | 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine | 1218790-39-6 | C12H15BF3NO2 |
|
2-三氟甲基吡啶-4-甲醛 | 2-(trifluoromethyl)isonicotinaldehyde | 108338-20-1 | C7H4F3NO |
|
2-三氟甲基吡啶 | 2-(trifluoromethyl)pyridine | 368-48-9 | C6H4F3N |
|
2-三氟甲基-喹啉-8-羧酸 | 2-trifluoromethyl-8-quinolinecarboxylic acid | 588702-63-0 | C11H6F3NO2 |
|
2-三氟甲基-8-羟基喹啉 | 2-trifluoromethyl-8-hydroxyquinoline | 41192-80-7 | C10H6F3NO |
|
2-三氟甲基-5-羟基嘧啶 | 2-(trifluoromethyl)pyrimidin-5-ol | 100991-09-1 | C5H3F3N2O |
|
2-三氟甲基-5-硝基-4,6-二氯嘧啶 | 4,6-dichloro-5-nitro-2-trifluoro-methyl-pyrimidine | 715-46-8 | C5Cl2F3N3O2 |
|
2-三氟甲基-5-氯甲基吡啶 | 3-chloromethyl-6-(trifluoromethyl)pyridine | 386715-33-9 | C7H5ClF3N |
|
2-三氟甲基-5-氨基-4,6-二氯嘧啶 | 4,6-Dichlor-5-amino-2-trifluormethylpyrimidin | 2344-17-4 | C5H2Cl2F3N3 |
|
2-三氟甲基-5-吡啶硼酸 | 6-(trifluoromethyl)-3-pyridinylboronic acid | 868662-36-6 | C6H5BF3NO2 |
|
2-三氟甲基-4-羟基吡啶 | 2-(trifluoromethyl)pyridin-4-ol | 170886-13-2 | C6H4F3NO |
|
2-三氟甲基-4-羟基-8-氟喹啉 | 8-fluoro-2-(trifluoromethyl)-4-quinolinone | 31009-31-1 | C10H5F4NO |
|
2-三氟甲基-4-甲基嘧啶-5-羧酸乙酯 | ethyl 4-methyl-2-(trifluoromethyl)pyrimidine-5-carboxylate | 306960-67-8 | C9H9F3N2O2 |
|
2-三氟甲基-4-溴吡啶 | 4-bromo-2-(trifluoromethyl)pyridine | 887583-90-6 | C6H3BrF3N |
|
2-三氟甲基-4-氯嘧啶-5-羧酸乙酯 | ethyl 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylate | 720-01-4 | C8H6ClF3N2O2 |
|
2-三氟甲基-4-氯嘧啶 | 4-chloro-2-(trifluoromethyl)pyrimidine | 1514-96-1 | C5H2ClF3N2 |
|
2-三氟甲基-4-氯吡啶 | 4-chloro-2-trifluoromethylpyridine | 131748-14-6 | C6H3ClF3N |
|
2-三氟甲基-4-氨基吡啶 | 2-(trifluoromethyl)pyridin-4-amine | 147149-98-2 | C6H5F3N2 |
|
2-三氟甲基-4-嘧啶甲酸甲酯 | methyl 2-(trifluoromethyl)pyrimidine-4-carboxylate | 878745-51-8 | C7H5F3N2O2 |
|
2-三氟甲基-4,6-二羟基嘧啶 | 2-trifluoromethyl-4,6-dihydroxypyrimidine | 672-47-9 | C5H3F3N2O2 |
|
2-三氟甲基-3-溴-6-羟基吡啶 | 5-bromo-6-(trifluoromethyl)pyridin-2(1H)-one | 1214383-87-5 | C6H3BrF3NO |
|
2-三氟甲基-3-氨基吡啶 | 3-amino-2-(trifluoromethyl)pyridine | 106877-32-1 | C6H5F3N2 |
|
2-三氟甲基-3-氟吡啶 | 3-fluoro-2-(trifluoromethyl)pyridine | 886510-21-0 | C6H3F4N |
|
2-丁基辛酸 | 2-butyloctanoic acid | 27610-92-0 | C12H24O2 |
|
2-丁基苯并呋喃 | 2-n-butylbenzo[b]furan | 4265-27-4 | C12H14O |
|
2-丁基-5-硝基苯并呋喃 | 2-butyl-5-nitrobenzofuran | 133238-87-6 | C12H13NO3 |
|
2-丁基-4-氯喹啉 | 2-n-butyl-4-chloroquinoline | 144624-27-1 | C13H14ClN |
|
2-丁基-3-甲基吡嗪 | 2-n-butyl-3-methylpyrazine | 15987-00-5 | C9H14N2 |
|
2-丁基-1,6-二氢-N,N,4-三甲基-6-氧代-5-嘧啶乙酰胺 | 2-(2-n-butyl-4-hydroxy-6-methylpyrimidin-5-yl)-N,N-dimethylacetamide | 1315478-13-7 | C13H21N3O2 |
|
2-丁基-1,2-苯并异噻唑啉-3-酮 | 2-butyl-1,2-benzothiazolin-3-one | 4299-07-4 | C11H13NOS |
|
2-{[4-(3-羟基丙氧基)-3-甲基吡啶-2-基]甲硫基}-1H-苯并咪唑 | 3-{{2-{[(1H-benzoimidazol-2-yl)thio]methyl}-3-methylpyridin-4-yl}oxy}propan-1-ol | 117976-91-7 | C17H19N3O2S |
|
2-[氯(4-氯苯基)甲基]吡啶 | 2-[chloro(4-chlorophenyl)methyl]pyridine | 142404-69-1 | C12H9Cl2N |
|
2-[双(叔丁氧羰基)氨基]-5-溴嘧啶 | 2-[bis(tert-butoxycarbonyl)amino]-5-bromopyrimidine | 209959-33-1 | C14H20BrN3O4 |
|
2-[[[4-(3-甲氧基丙氧基)-3-甲基吡啶-2-基]甲基]硫代]-1H-苯并咪唑 | rabeprazole sulfide | 117977-21-6 | C18H21N3O2S |
|
2-[[4-(2-吡啶基氨基磺酰基)苯基]偶氮]羟基苯 | 4-(2-hydroxy-phenylazo)-<i>N</i>-pyridin-2-yl-benzenesulfonamide | 66364-70-3 | C17H14N4O3S |
|
2-[[4-(2-吡啶基)苯基]甲基]-肼羧酸-(1,1-二甲基)乙酯 | N-1-(tert-butoxycarbonyl)-N-2-[4-(pyridine-2-yl)benzyl]hydrazine | 198904-85-7 | C17H21N3O2 |
|
2-[[4-(2,6-二氯-4-硝基苯基)偶氮苯基]-(2-甲氧羰基氧基乙基)氨基]乙基甲基碳酸酯 | 2,4,10-Trioxa-7-azaundecan-11-oic acid, 7-[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]-3-oxo-, methyl ester | 10347-09-8 | C20H20Cl2N4O8 |
|
2-[[3-(三氟乙基)苯基]氨基]吡啶-3-磺酸 | 2-(m-Trifluormethyl-anilino)-pyridin-3-sulfonsaeure | 38025-91-1 | C12H9F3N2O3S |
|
2-[[1-[2-(4-氟苯基)-2-氧代乙基]-4-哌啶基]甲基]-2,3-二氢-1H-异吲哚-1-酮 | roluperidone | 359625-79-9 | C22H23FN2O2 |
|
2-[[(5S)-2-氧代-3-[4-(3-氧代-4-吗啉基)苯基]-5-噁唑烷基]甲基]-1H-异吲哚-1,3(2H)-二酮 | 2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione | 446292-08-6 | C22H19N3O6 |
|
2-[[(4-硝基-3-甲基-2-吡啶)-2-甲基]硫代]-1H-苯并咪唑 | 2-[(4-nitro-3-methylpyridin-2-yl)methylsulfanyl]-1H-benzoimidazole | 152402-98-7 | C14H12N4O2S |
|
2-[[(4-甲氧基-3-甲基-2-吡啶基)甲基]硫基]-6-(1H-吡咯-1-基)-1H-苯并咪唑 | ilaprazole sulfide | 172152-35-1 | C19H18N4OS |
|
2-[[(3aR,4S,6R,6aS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧基]乙醇 | 2-(((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | 274693-55-9 | C10H19NO4 |
|
2-[[(3aR,4S,6R,6aS)-6-[[5-氨基-6-氯-2-(丙硫基)-4-嘧啶基]氨基]四氢-2,2-二甲基-4H-环戊烯并-1,3-二恶茂-4-基]氧基]乙醇 | 2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | 376608-74-1 | C17H27ClN4O4S |
|
2-[N-甲基-N-(2-吡啶基)氨基]乙醇 | 2-(N-methyl-N-(pyridin-2-yl)amino)ethanol | 122321-04-4 | C8H12N2O |
|
2-[N,正双(三氟甲烷烷磺酰)氨基]-5-氯吡啶 | Comins' reagent | 145100-51-2 | C7H3ClF6N2O4S2 |
|
2-[6-氧代-1(6H)-哒嗪基]乙酸 | 2-(6-oxopyridazin-1(6H)-yl)acetic acid | 95209-84-0 | C6H6N2O3 |
|
2-[5-(溴甲基)吡啶-2-基]-5-甲基吡啶 | 5-bromomethyl-5'-methyl-2,2'-bipyridine | 117585-58-7 | C12H11BrN2 |
|
2-[4-正(己氧基)苯基]-5-正辛基嘧啶 | 2-(4-Hexyloxyphenyl)-5-octylpyrimidine | 57202-48-9 | C24H36N2O |
|
2-[4-[(4-氯苯基)苯基甲基]哌嗪-1-基]乙醇 | 2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethan-1-ol | 109806-71-5 | C19H23ClN2O |
|